List view / Grid view
Quotient Clinical, the drug development services organisation, announces its renaming to Quotient Sciences (Quotient), following the acquisitions of Co-Formulate, QS Pharma and SeaView Research...
Studies show cell-based treatment is safe in patients with dry macular degeneration, with one showing improved vision...
ProCellics™, first in-line and real-time bioprocess raman analyser, is a RESOLUTION Spectra Systems product. It offers a GMP user-friendly and easily deployed Process Analytical Technology (PAT) solution...
The EU has approved a new subcutaneous formulation of Benlysta, as an add-on therapy in adult patients with active autoantibody-positive systemic lupus erythematosus...
The FDA has approved the first drug in the U.S. with a digital ingestion tracking system that records that the medication was taken...
In April 2018, changes to energy efficiency regulations will mean that every non-domestic privately rented property must have an EPC rating of at least an E. Here, John Rush, discusses three tips for improving the energy efficiency of HVAC systems in laboratories...
The FDA has approved the supplemental New Drug Application for Vraylarfor the maintenance treatment of adults with schizophrenia...
European Pharmaceutical Review welcomes the newest member of its Editorial Advisory Board
10 November 2017 | By
The EMA has recommended granting a marketing authorisation Prevymis, an antiviral medicine that prevents CMV reactivation and disease...
The findings from the two pivotal phase 3 trials pave the way for ozanimod to enter the New Drug Approval process with the FDA...
The vaccine that protects against cancer-causing types of human papillomavirus also prevents an uncommon but incurable childhood respiratory disease...
In vitro study verifies method for remotely triggering release of cancer drugs...
Company establishes its presence in South Korea...
NHS England has announced a commercial agreement that allows patients in England immediate access to the innovative new multiple sclerosis treatment...
A study has shown that Adipocytes can absorb and metabolise the chemotherapeutic agent daunorubicin, reducing its ability to kill cancer cells.
